Early Diagnosis Of Cancer Saves Human Lives
Light-Hope Dx is a US-based multinational company that develops PCR-based test for early cancer detection using liquid biopsy
Welcome to Light-Hope Diagnostics, Inc.
Our Mission
We are dedicated to providing a non-invasive method for an accurate early diagnosis of human cancer affordable to everyone everywhere.
About Light-Hope Diagnostics, Inc.
Our Vision
Our Innovation
Our Expertise
- At Light-Hope Diagnostics, Inc., our vision is to be a global leader in providing an accurate, affordable, and non-invasive test for early diagnosis of multiple forms of cancer to everyone around the globe and save countless human lives.
Our Expertise
Our Innovation
Our Expertise
- Our team at Light-Hope Diagnostics, Inc. is comprised of experienced scientists in the area of cancer and RNA biology, seasoned business professionals, advisors, and legal consultants with over 25 years of experience in their fields. This unique combination of dedicated professionals is the secret sauce of our success.
Our Innovation
Our Innovation
Our Innovation
- We utilize innovative PCR technology to detect a panel of our proprietary small non-coding RNAs in human serum for early diagnosis of cancer. In addition, our proprietary freeze-drying method for long-term stabilization of in-vitro diagnostic (IVD) products at a higher temperature eliminates cold-chain and make them accessible and affordable globally.
Innovative Diagnostics Solutions
Why Early Diagnosis of Cancer Matters?
The importance of Early Cancer Diagnosis is underscored by the World Health Organisation as below.
"Early diagnosis of cancer focuses on detecting symptomatic patients as early as possible so they have the best chance for successful treatment. When cancer care is delayed or inaccessible there is a lower chance of survival, greater problems associated with treatment and higher costs of care. Early diagnosis improves cancer outcomes by providing care at the earliest possible stage and is therefore an important public health strategy in all settings." Light-Hope Diagnostics, Inc. is at the forefront of developing non-invasive tests for early cancer diagnosis by detecting cancer-specific non-coding RNAs in liquid biopsy. RNA is a robust biomarker for early detection of human cancer with high specificity and sensitivity.
Our Ongoing Projects
We are currently performing the analytical/clinical validation of our first PCR-based IVD product for early diagnosis of breast cancer. Our tests rely on RNA biomarkers, which are a group of genetic markers present in liquid biopsy (blood, urine, and saliva). The RNA-based early detection of cancer using liquid biopsy is a promising technology that has potential to revolutionize cancer diagnosis and screening, and save countless human lives.
Our forthcoming IVD products for early diagnosis of the following cancer are in the research and development phase.
- Ovarian cancer
- Lung Cancer
- Pancreatic Cancer
- Prostate Cancer
Our long-term goal is to develop a Multi-cancer Early Detection (MCED) Test which can simultaneously detect at least five major forms of human cancer, namely, breast, ovarian, lung, pancreatic, and prostate.
Ensuring Affordability and Accessibility of Our IVD Products Worldwide
Cold chain management is essential for maintaining the stability of PCR-based IVD products. Utilizing our 20+ years of experience in enzymology, DNA/RNA biochemistry, and protein science, we have developed a proprietary freeze-drying (lyophilization) method for long-term stabilization of our IVD products at a higher ambient temperature (60-120 degree Fahrenheit). This feature virtually eliminates the cold chain requirement for our products (even in tropical countries, e.g., India, Africa) and markedly reduces their cost--and thereby makes them affordable and accessible worldwide.
Executive Team at Light-Hope Diagnostics, Inc.
Raushan Singh, PhD Founder and CEO
Raushan Singh, PhD Founder and CEO
Raushan Singh, PhD Founder and CEO
- Raushan is the Founder and CEO of Light-Hope Diagnostics, Inc. Prior to founding Light-Hope, Raushan worked as a Scientist III at Co-Diagnostics, Inc., where he led the long-term stabilization efforts of IVD products. He earned his PhD (Biochemistry) from North Dakota State University, Fargo(USA). He completed his post-doctoral fellowshi
- Raushan is the Founder and CEO of Light-Hope Diagnostics, Inc. Prior to founding Light-Hope, Raushan worked as a Scientist III at Co-Diagnostics, Inc., where he led the long-term stabilization efforts of IVD products. He earned his PhD (Biochemistry) from North Dakota State University, Fargo(USA). He completed his post-doctoral fellowships at the University of Massachusetts Medical School (UMASS) and the University of Utah School of Medicine. His interest in the RNA world was primarily shaped by the pioneer RNA biologists, namely, Dr. Victor Ambros (Nobel Prize 2024) and Dr. Craig Mello (Nobel Prize 2006) while he was an American Heart Association postdoctoral fellow at the UMASS. He has published 14 research papers in prestigious journals (Cell Reports, eLife, Molecular Pharmaceutics, JBC, etc.). He has developed two anticancer drugs which are now commercialized by multiple US biotech companies. He was an invited Early Career Reviewer in Structural Biology & Molecular Biophysics for eLife, a prestigious journal. Raushan was born and raised under humble circumstances in India. He received his BS (Biotechnology, and Entrepreneurship Development) with distinction (class topper) from Patna University (India), and MS (Animal Biotechnology) from National Dairy Research Institute (India). He was a CSIR Junior Research Fellow at the University of Delhi South Campus, New Delhi. He is a recipient of several prestigious scholarships in India during his academic career. Raushan is an avid hiker and a passionate cook. In his free time, he enjoys playing harmonium/piano and singing Indian classical music.
Emily Hope, COO
Raushan Singh, PhD Founder and CEO
Raushan Singh, PhD Founder and CEO
- Emily comes with 20 years of passion for financial organization in start-ups. She is a highly organized and motivated finance professional who is dedicated to creating financial organization and best practices for small businesses and start-ups. She has a propensity for leading by example, employee development, and team building. She is
- Emily comes with 20 years of passion for financial organization in start-ups. She is a highly organized and motivated finance professional who is dedicated to creating financial organization and best practices for small businesses and start-ups. She has a propensity for leading by example, employee development, and team building. She is known for building systems and structures that high-level professionals feel confident in building upon
Jim Herrin, MBA Financial Advisor
Durga Mohanty, BS, MBA Business Advisor (India)
Durga Mohanty, BS, MBA Business Advisor (India)
- Jim Herrin, Director of the Salt Lake Region Small Business Development Center (SBDC), brings over 35 years of experience to assisting small business entrepreneurs in Utah. He began his career as an intern, then international trade specialist with the State of Utah. After seven years, he was recruited to a small company and worked many ye
- Jim Herrin, Director of the Salt Lake Region Small Business Development Center (SBDC), brings over 35 years of experience to assisting small business entrepreneurs in Utah. He began his career as an intern, then international trade specialist with the State of Utah. After seven years, he was recruited to a small company and worked many years in biomedical R&D where he held key positions such as CFO, Senior Vice President of Finance and Corporate Development, and Director of Business Development. Jim was key to raising many millions of dollars in equity funding, co-founded two other companies, and facilitated a merger/sale of the first business to a British pharmaceutical company. In 2012, Jim joined the Utah SBDC Network as the Associate State Director, then Acting State Director. In 2014 he became the Director of the Salt Lake Region SBDC. He also started and runs the Utah SBDC Network’s Global Trade Center. For several years Jim concurrently taught masters-level business finance at Webster University on Hill Airforce Base, and currently serves as the Treasurer of the Utah District Export Council and on the executive committee of the Utah Microloan Fund Board of Trustees. Jim holds an MBA from the University of Utah and a BA from BYU in Korean Studies. He and his wife of 40 years enjoy being with their family of three grown children and nine grandchildren.
Durga Mohanty, BS, MBA Business Advisor (India)
Durga Mohanty, BS, MBA Business Advisor (India)
Durga Mohanty, BS, MBA Business Advisor (India)
- Durga Prasad Mohanty is a seasoned business professional with over 27 years of experience in Diagnostics & Life Science industry, specializing in building and scaling up business in the molecular Diagnostics space in India. With a robust academic foundation-- holding a B. Sc. (Chemistry), a B. Tech (Electronics & Communication Engineering
- Durga Prasad Mohanty is a seasoned business professional with over 27 years of experience in Diagnostics & Life Science industry, specializing in building and scaling up business in the molecular Diagnostics space in India. With a robust academic foundation-- holding a B. Sc. (Chemistry), a B. Tech (Electronics & Communication Engineering), and an MBA from the Indian Institute of Management (IIM) Calcutta--he brings a unique multidisciplinary perspective to diagnostics industry in the healthcare sector. Throughout his career, he has played a pivotal role in establishing and expanding business operations for leading multinational molecular diagnostics companies, namely, bioMérieux, Roche, Qiagen, Co-Diagnostics, in India, driving their strategic growth, market penetration and operational excellence. His expertise spans business strategy, team leadership, market development and fostering cross functional collaborations in high stake environments in Molecular diagnostics Industry and achieved a double-digit growth year on year. He is recognized for his innovative thinking, leadership skills and industry knowledge. e is passionate about advancing healthcare solutions and enabling access to cutting edge healthcare solutions in molecular diagnostics technologies that improves patient outcome. Currently as a leader of sales and business development for a multinational corporation specializing in critical molecular diagnostics testing, the role involves driving strategic growth and market leadership in healthcare domain.
Our Advisors
Don Weil, MBA(Harvard Business School)
Don Weil, MBA(Harvard Business School)
Don Weil, MBA(Harvard Business School)
- Don is an entrepreneur and angel investor with a background from Harvard Business School and the US Naval Academy. As an angel investor, he was an active member of three investment groups. Before retiring, he owned and operated four foundries specializing in aluminum castings for high-tech and medical industries. Additionally, he owned a
- Don is an entrepreneur and angel investor with a background from Harvard Business School and the US Naval Academy. As an angel investor, he was an active member of three investment groups. Before retiring, he owned and operated four foundries specializing in aluminum castings for high-tech and medical industries. Additionally, he owned a metals distribution center, a plumbing supply business, and founded a small engineering company. After retirement, Don invested in and led the company responsible for towing cars for the city of San Francisco. He also worked for Olin Corporation (Fortune 500 company) prior to becoming an entrepreneur
Brinda Wiita, PhD, MBA
Don Weil, MBA(Harvard Business School)
Don Weil, MBA(Harvard Business School)
- Brinda Wiita is the Founder and President of Open Mind Innovation, a pharmaceutical scientific consulting company focused on developing innovative products and generating value for Rx and over-the-counter drugs and medical devices in several therapeutic areas. Over 35+ years in the pharmaceutical and consumer industry, her responsibilitie
- Brinda Wiita is the Founder and President of Open Mind Innovation, a pharmaceutical scientific consulting company focused on developing innovative products and generating value for Rx and over-the-counter drugs and medical devices in several therapeutic areas. Over 35+ years in the pharmaceutical and consumer industry, her responsibilities have included product design, preclinical testing, clinical research, medical communications, and medical affairs at Johnson & Johnson, Abbvie, and GSK. At Johnson & Johnson, her focus area in Business Development was worldwide evaluation and licensing of technologies. Brinda’s academic research was conducted at Cambridge University, All-India Institute of Medical Sciences, University of Chicago, and Thomas Jefferson University. Currently, Brinda is Chief Scientific Officer at a microbiome therapeutics company, a SCORE mentor advising healthcare startups, and a consultant for entrepreneurs and startups at University of California San Francisco ( UCSF) and Berkeley.
Marlin Shelley, MBA
Don Weil, MBA(Harvard Business School)
Marlin Shelley, MBA
- Marlin Shelley was the founder and President of Cirris Systems Corporation, a leading supplier of cable and harness test equipment. His frustration with wiring defects inspired him in the 1980’s to develop and patent a cable tester that has since become an industry standard. Marlin spent his childhood taking things apart and occasionally
- Marlin Shelley was the founder and President of Cirris Systems Corporation, a leading supplier of cable and harness test equipment. His frustration with wiring defects inspired him in the 1980’s to develop and patent a cable tester that has since become an industry standard. Marlin spent his childhood taking things apart and occasionally fixing them. Being fascinated with electronics at a young age Marlin built upon this childhood love, completing a bachelor’s degree in electrical engineering, followed by a master’s in engineering, and then an MBA (University of Utah). He is a past recipient of the State of Utah’s Governor’s Medal for Science and Technology, and a holder of three US Patents.
The Global Presence of Light-Hope Dx
Light-Hope Diagnostics, Inc. is a resident at AIC-CCMB, Hyderabad (India); https://aic.ccmb.res.in/
We are currently present in the USA and India. Our presence in India is important for the company growth globally with the following objectives.
1. To manufacture our IVD products at low cost.
2. To perform cost-effective clinical trial of our products on Indian population (in collaboration with cancer hospitals in India).
3. To provide affordable methods for early cancer detection to millions of low-income Indian after the regulatory approval of our product by the CDSCO (the Indian FDA).
4. To participate in MAKE IN INDIA initiative of the Government of India(https://www.pmindia.gov.in/en/major_initiatives/make-in-india/), and to secure non-dilutive funding from the Indian federal government, namely, BIRAC; https://www.birac.nic.in/
Our Partners
